Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Colon Cancer

Join Al B. Benson III, MD (Medical Oncologist) and William Small, Jr., MD (Radiation Oncologist) as they present their multidisciplinary expertise on a range of cases pertaining to colon cancer.

Since patients are heterogeneous, patient management should also be individualized. The cases in this webinar are designed to highlight significant clinical decision points concerning treatment selection, toxicity management, and areas of recent change or controversy in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) while reinforcing emerging data from clinical trials. This webinar will allow learners to understand how to apply the standards of care to their practice and healthcare setting.

Approximately 50%-60% of patients with colorectal cancer develop metastases. The management of both resectable and unresectable metastatic colorectal cancer involves a continuum of care in which patients are exposed sequentially to a variety of active agents (5-FU/leucovorin, capecitabine, irinotecan, oxaliplatin, bevacizumab, cetuximab, panitumumab), either in combinations or as single agents. The choice of therapy is based on consideration of the goals of therapy (i.e., eradication of micrometastases in resectable patients, tumor shrinkage to obtain resectability, slowing of disease in unresectable patients), the type and timing of prior therapy, the KRAS status of the tumor, and the different efficacy and toxicity profiles of the drugs.

In patients with colon cancer, clinicians need to be aware of the stage of the disease, the markers of the patient, and the previous treatment history. Molecular testing has played an increasingly important role for the determination of adjuvant therapy. The choice of therapy is based on consideration of the goals of therapy (i.e., eradication of micro-metastases in resectable patients, tumor shrinkage to obtain resectability, slowing of disease in unresectable patients), the type and timing of prior therapy, the KRAS status of the tumor and the different efficacy and toxicity profiles of the drugs.

Target Audience

This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Apply NCCN Guideline-based therapeutic strategies for colon cancer in the treatment of patients.
  • Describe the multidisciplinary aspects of patient management for colon cancer.
  • Identify the key characteristics for colon cancer that trigger decision points.
  • Recognize situations where optimal care may require adapting the guideline recommendations to individual circumstances.
Additional information
Supporters: 

This activity is supported by educational grants from:

  • Daiichi Sankyo, Inc.
  • Genentech
  • Millennium: The Takeda Oncology Company
  • Novartis Pharmaceuticals Corporation
  • Teva Pharmaceuticals

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

This activity is supported by a grant from Onyx Pharmaceuticals.

Course summary
Available credit: 
  • 1.00 Participation
  • 0.98 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
07/19/2013
Course expires: 
07/19/2014
Cost:
$0.00

Al B. Benson III, MD
Robert H. Lurie Comprehensive Cancer
Center of Northwestern University
Chicago, Illinois


William Small, Jr., MD
Robert H. Lurie Comprehensive Cancer
Center of Northwestern University
Chicago, Illinois

Available Credit

  • 1.00 Participation
  • 0.98 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician

Accreditation Period

Course opens: 
07/19/2013
Course expires: 
07/19/2014

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To access this activity, users will need:

  • A device with an Internet connection and sound playback capability
  • Adobe Flash Player and/or an HTML5 capable browser for video or audio playback
  • For Windows: JavaScript and cookies enabled, Active X enabled and unblocked for Microsoft Internet Explorer, Java 6.0 or above
  • For Mac: JavaScript and cookies enabled, Plug-ins enabled in Safari, Java 6.0 or above
  • Adobe Reader or other PDF reader software for certificate viewing/printing